{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:32:58Z","timestamp":1778243578572,"version":"3.51.4"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01006"],"award-info":[{"award-number":["PI19\/01006"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015068","name":"Universidade de Santiago de Compostela","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015068","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s40264-023-01302-7","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T03:24:19Z","timestamp":1686021859000},"page":"625-636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update"],"prefix":"10.1007","volume":"46","author":[{"given":"Patricia","family":"Garc\u00eda-Abeijon","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8247-0422","authenticated-orcid":false,"given":"Catarina","family":"Costa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1243-8352","authenticated-orcid":false,"given":"Margarita","family":"Taracido","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0500-4049","authenticated-orcid":false,"given":"Maria Teresa","family":"Herdeiro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5542-9993","authenticated-orcid":false,"given":"Carla","family":"Torre","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5766-8672","authenticated-orcid":false,"given":"Adolfo","family":"Figueiras","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"issue":"5","key":"1302_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.medcli.2019.08.007","volume":"154","author":"E Montan\u00e9","year":"2020","unstructured":"Montan\u00e9 E, Santesmases J. Adverse drug reaction. Med Clin (Bar). 2020;154(5):178\u20131842.","journal-title":"Med Clin (Bar)."},{"issue":"7\u20138","key":"1302_CR2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1345\/aph.1P627","volume":"45","author":"SV Tach\u00e9","year":"2011","unstructured":"Tach\u00e9 SV, S\u00f6nnichsen A, Ashcroft DM. Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother. 2011;45(7\u20138):977\u201389. https:\/\/doi.org\/10.1345\/aph.1P627.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"1302_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40264-015-0281-0","volume":"38","author":"JC Bouvy","year":"2015","unstructured":"Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015;38(5):437\u201353. https:\/\/doi.org\/10.1007\/s40264-015-0281-0.","journal-title":"Drug Saf"},{"issue":"4","key":"1302_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/jama.284.4.483","volume":"284","author":"B Starfield","year":"2000","unstructured":"Starfield B. Is US health really the best in the world? JAMA. 2000;284(4):483\u20135. https:\/\/doi.org\/10.1001\/jama.284.4.483.","journal-title":"JAMA"},{"key":"1302_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(98)80007-6","author":"SA Goldman","year":"1998","unstructured":"Goldman SA. Limitations and strengths of spontaneous reports data. Clin Ther. 1998. https:\/\/doi.org\/10.1016\/S0149-2918(98)80007-6.","journal-title":"Clin Ther"},{"issue":"5","key":"1302_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200932010-00002","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SAW. Under-reporting of adverse drug reactions. A systematic review. Drug Saf. 2006;29(5):385\u201396. https:\/\/doi.org\/10.2165\/00002018-200932010-00002.","journal-title":"Drug Saf."},{"key":"1302_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2165\/00002018-200528090-00007","volume":"28","author":"MT Herdeiro","year":"2005","unstructured":"Herdeiro MT, Figueiras A, Pol\u00f3nia J, et al. Physicians\u2019 attitudes and adverse drug reaction reporting. Drug Saf. 2005;28:825\u201333. https:\/\/doi.org\/10.2165\/00002018-200528090-00007.","journal-title":"Drug Saf."},{"issue":"1","key":"1302_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00002018-200932010-00002","volume":"32","author":"E Lopez-Gonzalez","year":"2009","unstructured":"Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32(1):19\u201331.","journal-title":"Drug Saf"},{"issue":"12","key":"1302_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011458","volume":"6","author":"MJ Downes","year":"2016","unstructured":"Downes MJ, Brennan ML, Williams HC, Dean RS. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016;6(12): e011458.","journal-title":"BMJ Open"},{"key":"1302_CR10","first-page":"13","volume-title":"Monitoring for drug safety","author":"WHW Inman","year":"1986","unstructured":"Inman WHW, Weber JCT. The United Kingdom. In: Inman WHW, editor. Monitoring for drug safety. 2nd ed. Lancaster: MTP Press Ltd; 1986. p. 13\u201347.","edition":"2"},{"key":"1302_CR11","first-page":"17","volume-title":"Epidemiological issues in reported drug-induced illnesses","author":"WHW Inman","year":"1976","unstructured":"Inman WHW. Assessment of drug safety problems. In: Gent M, Shigmatsu I, editors. Epidemiological issues in reported drug-induced illnesses. Honolulu: McMaster University Library Press; 1976. p. 17\u201324."},{"issue":"5","key":"1302_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1365-2125.1996.tb00040.x","volume":"41","author":"WH Inman","year":"1996","unstructured":"Inman WH. Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol. 1996;41(5):434\u20135.","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"1302_CR13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00228-020-02862-8","volume":"76","author":"HM Haines","year":"2020","unstructured":"Haines HM, Meyer JC, Summers RS, Godman BB. Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district. Eur J Clin Pharmacol. 2020;76(7):991\u20131001.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"1302_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034553","volume":"10","author":"K Gidey","year":"2020","unstructured":"Gidey K, Seifu M, Hailu BY, Asgedom SW, Niriayo YL. Healthcare professionals knowledge, attitude and practice of adverse drug reactions reporting in Ethiopia: a cross-sectional study. BMJ Open. 2020;10(2): e034553.","journal-title":"BMJ Open"},{"issue":"1","key":"1302_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0227712","volume":"15","author":"SS Nadew","year":"2020","unstructured":"Nadew SS, Beyene KG, Beza SW. Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia. PLoS ONE. 2020;15(1):1\u201319.","journal-title":"PLoS ONE"},{"issue":"4","key":"1302_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.5530\/jyp.2020.12.92","volume":"12","author":"JRR Melo","year":"2020","unstructured":"Melo JRR, Duarte EC, de Ara\u00fajo FK, et al. Under-reporting of adverse drug reactions among healthcare professionals in Brazil: an estimate based on national pharmacovigilance survey. J Young Pharm. 2020;12(4):360\u20135.","journal-title":"J Young Pharm"},{"issue":"4","key":"1302_CR17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3917\/spub.194.0553","volume":"31","author":"R Braiki","year":"2019","unstructured":"Braiki R, Douville F, Hasine AB, Souli I. Facteurs li\u00e9s au signalement des \u00e9v\u00e8nements ind\u00e9sirables associ\u00e9s aux soins dans un h\u00f4pital Tunisien. Sante Publique. 2019;31(4):553\u20139.","journal-title":"Sante Publique"},{"key":"1302_CR18","doi-asserted-by":"crossref","unstructured":"Kassa Alemu B, Biru TT. Health care professionals' knowledge, attitude, and practice towards adverse drug reaction reporting and associated factors at selected public hospitals in Northeast Ethiopia: a cross-sectional study. Biomed Res Int. 2019; 8690546.","DOI":"10.1155\/2019\/8690546"},{"issue":"1","key":"1302_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/jcpt.13037","volume":"45","author":"TT Le","year":"2020","unstructured":"Le TT, Nguyen TTH, Nguyen C, Tran NH, Tran LA, Nguyen TB, Nguyen N, Nguyen HA. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam. J Clin Pharm Ther. 2020;45(1):122\u20137.","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"1302_CR20","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1002\/pds.4792","volume":"28","author":"D Kopciuch","year":"2019","unstructured":"Kopciuch D, Zaprutko T, Paczkowska A, Ratajczak P, Zieli\u0144ska-Tomczak \u0141, Kus K, Nowakowska E. Safety of medicines-pharmacists\u2019 knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Pharmacoepidemiol Drug Saf. 2019;28(12):1543\u201351.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"1302_CR21","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/pds.4800","volume":"28","author":"ML Hughes","year":"2019","unstructured":"Hughes ML, Weiss M. Adverse drug reaction reporting by community pharmacists\u2014the barriers and facilitators. Pharmacoepidemiol Drug Saf. 2019;28(12):1552\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"1302_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/0018578719883796","volume":"56","author":"K Danekhu","year":"2021","unstructured":"Danekhu K, Shrestha S, Aryal S, Shankar PR. Health-care professionals\u2019 knowledge and perception of adverse drug reaction reporting and pharmacovigilance in a tertiary care teaching hospital of Nepal. Hosp Pharm. 2021;56(3):178\u201386.","journal-title":"Hosp Pharm"},{"issue":"1","key":"1302_CR23","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1186\/s12913-019-4775-9","volume":"19","author":"R Adisa","year":"2019","unstructured":"Adisa R, Omitogun TI. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria. BMC Health Serv Res. 2019;19(1):926.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"1302_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/inthealth\/ihy073","volume":"11","author":"Y Erg\u00fcn","year":"2019","unstructured":"Erg\u00fcn Y, Erg\u00fcn TB, Toker E, \u00dcnal E, Akben M. Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital. Int Health. 2019;11(3):177\u201384.","journal-title":"Int Health"},{"issue":"1","key":"1302_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jcpt.12756","volume":"44","author":"A Thompson","year":"2019","unstructured":"Thompson A, Randall C, Howard J, Barker C, Bowden D, Mooney P, et al. Nonmedical prescriber experiences of training and competence to report adverse drug reactions in the UK. J Clin Pharm Ther. 2019;44(1):78\u201383.","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"1302_CR26","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s11096-018-0700-2","volume":"40","author":"R Li","year":"2018","unstructured":"Li R, Curtain C, Bereznicki L, Zaidi STR. Community pharmacists\u2019 knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey. Int J Clin Pharm. 2018;40(4):878\u201389.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"1302_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s11096-018-0682-0","volume":"40","author":"MA Seid","year":"2018","unstructured":"Seid MA, Kasahun AE, Mante BM, Gebremariam SN. Healthcare professionals\u2019 knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia. Int J Clin Pharm. 2018;40(4):895\u2013902.","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"1302_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.26719\/2018.24.6.569","volume":"24","author":"A Bahnassi","year":"2018","unstructured":"Bahnassi A, Al-Harbi F. Syrian pharmacovigilance system: a survey of pharmacists\u2019 knowledge, attitudes and practices. East Mediterr Health J. 2018;24(6):569\u201378.","journal-title":"East Mediterr Health J"},{"issue":"1","key":"1302_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000487236","volume":"27","author":"J Lemay","year":"2018","unstructured":"Lemay J, Alsaleh FM, Al-Buresli L, Al-Mutairi M, Abahussain EA, Bayoud T. Reporting of Adverse Drug Reactions in Primary Care Settings in Kuwait: A Comparative Study of Physicians and Pharmacists. Med Princ Pract. 2018;27(1):30\u20138.","journal-title":"Med Princ Pract"},{"issue":"5","key":"1302_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/21548331.2017.1381013","volume":"45","author":"A Terblanche","year":"2017","unstructured":"Terblanche A, Meyer JC, Godman B, Summers RS. Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis. Hosp Pract (1995). 2017;45(5):238\u201345.","journal-title":"Hosp Pract (1995)."},{"issue":"1","key":"1302_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/03007995.2017.1361916","volume":"34","author":"A Hajj","year":"2018","unstructured":"Hajj A, Hallit S, Ramia E, Salameh P, Order of Pharmacists Scientific Committee \u2013 Medication Safety Subcommittee. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon. Curr Med Res Opin. 2018;34(1):149\u201356.","journal-title":"Curr Med Res Opin."},{"issue":"3","key":"1302_CR32","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/jep.12683","volume":"23","author":"K Abu Hammour","year":"2017","unstructured":"Abu Hammour K, El-Dahiyat F, Abu FR. Health care professionals knowledge and perception of pharmacovigilance in a tertiary care teaching hospital in Amman, Jordan. J Eval Clin Pract. 2017;23(3):608\u201313.","journal-title":"J Eval Clin Pract."},{"issue":"3","key":"1302_CR33","first-page":"931","volume":"15","author":"E Cheema","year":"2017","unstructured":"Cheema E, Haseeb A, Khan TM, Sutcliffe P, Singer DR. Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom. Pharm Pract. 2017;15(3):931.","journal-title":"Pharm Pract"},{"key":"1302_CR34","doi-asserted-by":"publisher","first-page":"5728462","DOI":"10.1155\/2016\/5728462","volume":"2016","author":"LT Gurmesa","year":"2016","unstructured":"Gurmesa LT, Dedefo MG. Factors affecting adverse drug reaction reporting of healthcare professionals and their knowledge, attitude, and practice towards ADR reporting in Nekemte Town, West Ethiopia. Biomed Res Int. 2016;2016:5728462.","journal-title":"Biomed Res Int"},{"issue":"12","key":"1302_CR35","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.15537\/smj.2016.12.17059","volume":"37","author":"NB Almandil","year":"2016","unstructured":"Almandil NB. Healthcare professionals\u2019 awareness and knowledge of adverse drug reactions and pharmacovigilance. Saudi Med J. 2016;37(12):1359\u201364.","journal-title":"Saudi Med J"},{"issue":"11","key":"1302_CR36","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s40264-016-0455-4","volume":"39","author":"S Stergiopoulos","year":"2016","unstructured":"Stergiopoulos S, Brown CA, Felix T, Grampp G, Getz KA. A survey of adverse event reporting practices among US healthcare professionals. Drug Saf. 2016;39(11):1117\u201327.","journal-title":"Drug Saf"},{"issue":"1","key":"1302_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/JRS-160670","volume":"28","author":"P Peymani","year":"2016","unstructured":"Peymani P, Tabrizi R, Afifi S, Namazi S, Heydari ST, Shirazi MK, et al. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report). Int J Risk Saf Med. 2016;28(1):25\u201331.","journal-title":"Int J Risk Saf Med"},{"issue":"8","key":"1302_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010912","volume":"6","author":"MN Amin","year":"2016","unstructured":"Amin MN, Khan TM, Dewan SM, Islam MS, Moghal MR, Ming LC. Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh. BMJ Open. 2016;6(8): e010912.","journal-title":"BMJ Open"},{"issue":"5","key":"1302_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155517","volume":"11","author":"YM Yu","year":"2016","unstructured":"Yu YM, Lee E, Koo BS, Jeong KH, Choi KH, Kang LK, Lee MS, Choi KH, Oh JM, Shin WG. Predictive factors of spontaneous reporting of adverse drug reactions among community pharmacists. PLoS ONE. 2016;11(5): e0155517.","journal-title":"PLoS ONE"},{"issue":"3","key":"1302_CR40","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/jonm.12337","volume":"24","author":"JI Mendes Marques","year":"2016","unstructured":"Mendes Marques JI, Pol\u00f3nia JM, Figueiras AG, Costa Santos CM, Herdeiro MT. Nurses\u2019 attitudes and spontaneous adverse drug reaction reporting: a case-control study in Portugal. J Nurs Manag. 2016;24(3):409\u201316.","journal-title":"J Nurs Manag"},{"issue":"2","key":"1302_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.pharma.2015.07.001","volume":"74","author":"L Cerruti","year":"2016","unstructured":"Cerruti L, Lebel D, Bussi\u00e8res JF. Perception de la pharmacovigilance par les pharmaciens hospitaliers qu\u00e9b\u00e9cois [Hospital pharmacists\u2019 perception of pharmacovigilance in Quebec]. Ann Pharm Fr. 2016;74(2):137\u201345.","journal-title":"Ann Pharm Fr"},{"issue":"4","key":"1302_CR42","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.4314\/ahs.v15i4.34","volume":"15","author":"B Katusiime","year":"2015","unstructured":"Katusiime B, Semakula D, Lubinga SJ. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda. Afr Health Sci. 2015;15(4):1308\u201317.","journal-title":"Afr Health Sci"},{"issue":"4","key":"1302_CR43","first-page":"277","volume":"51","author":"A De Angelis","year":"2015","unstructured":"De Angelis A, Giusti A, Colaceci S, Vellone E, Alvaro R. Nurses\u2019 reporting of suspect adverse drug reactions: a mixed-methods study. Ann Ist Super Sanita. 2015;51(4):277\u201383.","journal-title":"Ann Ist Super Sanita"},{"issue":"6","key":"1302_CR44","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s11096-015-0165-5","volume":"37","author":"TM Alshammari","year":"2015","unstructured":"Alshammari TM, Alamri KK, Ghawa YA, Alohali NF, Abualkol SA, Aljadhey HS. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia. Int J Clin Pharm. 2015;37(6):1104\u201310.","journal-title":"Int J Clin Pharm"},{"key":"1302_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.11604\/pamj.2015.20.70.3873","volume":"20","author":"F Nde","year":"2015","unstructured":"Nde F, Fah AB, Simo FA, Wouessidjewe D. State of knowledge of Cameroonian drug prescribers on pharmacovigilance. Pan Afr Med J. 2015;20:70.","journal-title":"Pan Afr Med J"},{"issue":"3","key":"1302_CR46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11096-015-0065-8","volume":"37","author":"J Liu","year":"2015","unstructured":"Liu J, Zhou Z, Yang S, Feng B, Zhao J, Liu H, Huang H, Fang Y. Factors that affect adverse drug reaction reporting among hospital pharmacists in Western China. Int J Clin Pharm. 2015;37(3):457\u201364.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"1302_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/0253-7613.150344","volume":"47","author":"VR Tandon","year":"2015","unstructured":"Tandon VR, Mahajan V, Khajuria V, Gillani Z. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India. Indian J Pharmacol. 2015;47(1):65\u201371.","journal-title":"Indian J Pharmacol."},{"issue":"4","key":"1302_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4314\/gmj.v48i4.4","volume":"48","author":"GT Sabblah","year":"2014","unstructured":"Sabblah GT, Akweongo P, Darko D, Dodoo AN, Sulley AM. Adverse drug reaction reporting by doctors in a developing country: a case study from Ghana. Ghana Med J. 2014;48(4):189\u201393.","journal-title":"Ghana Med J"},{"issue":"11","key":"1302_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005869","volume":"4","author":"R Kiguba","year":"2014","unstructured":"Kiguba R, Karamagi C, Waako P, Ndagije HB, Bird SM. Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants. BMJ Open. 2014;4(11): e005869.","journal-title":"BMJ Open"},{"issue":"3","key":"1302_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3233\/JRS-140620","volume":"26","author":"S Afifi","year":"2014","unstructured":"Afifi S, Maharloui N, Peymani P, Namazi S, Gharaei AG, Jahani P, Lankarani KB. Adverse drug reactions reporting: pharmacists\u2019 knowledge, attitude and practice in Shiraz. Iran Int J Risk Saf Med. 2014;26(3):139\u201345.","journal-title":"Iran. Int J Risk Saf Med."},{"issue":"2","key":"1302_CR51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/PTS.0000000000000051","volume":"10","author":"RM Elkalmi","year":"2014","unstructured":"Elkalmi RM, Hassali MA, Ibrahim MI, Jamshed SQ, Al-Lela OQ. Community pharmacists\u2019 attitudes, perceptions, and barriers toward adverse drug reaction reporting in Malaysia: a quantitative insight. J Patient Saf. 2014;10(2):81\u20137.","journal-title":"J Patient Saf"},{"issue":"11","key":"1302_CR52","doi-asserted-by":"publisher","first-page":"930","DOI":"10.26719\/2013.19.11.930","volume":"19","author":"K Wilbur","year":"2013","unstructured":"Wilbur K. Pharmacovigilance in Qatar: a survey of pharmacists. East Mediterr Health J. 2013;19(11):930\u20135.","journal-title":"East Mediterr Health J"},{"issue":"4","key":"1302_CR53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3233\/JRS-130598","volume":"25","author":"DR Sanghavi","year":"2013","unstructured":"Sanghavi DR, Dhande PP, Pandit VA. Perception of pharmacovigilance among doctors in a tertiary care hospital: influence of an interventional lecture. Int J Risk Saf Med. 2013;25(4):197\u2013204.","journal-title":"Int J Risk Saf Med"},{"issue":"2","key":"1302_CR54","first-page":"365","volume":"10","author":"V Stoynova","year":"2013","unstructured":"Stoynova V, Getov IN, Naseva EK, Lebanova HV, Grigorov EE. Physicians\u2019 knowledge and attitude towards adverse event reporting system and result to intervention-randomized nested trial among Bulgarian physicians. Med Glas (Zenica). 2013;10(2):365\u201372.","journal-title":"Med Glas (Zenica)."},{"issue":"8","key":"1302_CR55","doi-asserted-by":"publisher","first-page":"E22","DOI":"10.1038\/sj.bdj.2013.426","volume":"214","author":"J Yip","year":"2013","unstructured":"Yip J, Radford DR, Brown D. How do UK dentists deal with adverse drug reaction reporting? Br Dent J. 2013;214(8):E22.","journal-title":"Br Dent J"},{"key":"1302_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2050-6511-14-16","volume":"14","author":"KC Santosh","year":"2013","unstructured":"Santosh KC, Tragulpiankit P, Gorsanan S, Edwards IR. Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal. BMC Pharmacol Toxicol. 2013;14:16.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"2","key":"1302_CR57","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s11096-012-9739-7","volume":"35","author":"D Stewart","year":"2013","unstructured":"Stewart D, MacLure K, Paudyal V, Hughes C, Courtenay M, McLay J. Non-medical prescribers and pharmacovigilance: participation, competence and future needs. Int J Clin Pharm. 2013;35(2):268\u201374.","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"1302_CR58","first-page":"52","volume":"20","author":"R Agarwal","year":"2013","unstructured":"Agarwal R, Daher AM, Mohd IN. Knowledge, practices and attitudes towards adverse drug reaction reporting by private practitioners from Klang Valley in Malaysia. Malays J Med Sci. 2013;20(2):52\u201361.","journal-title":"Malays J Med Sci."},{"issue":"3\u20134","key":"1302_CR59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/0019-5359.110902","volume":"66","author":"SA Pimpalkhute","year":"2012","unstructured":"Pimpalkhute SA, Jaiswal KM, Sontakke SD, Bajait CS, Gaikwad A. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital. Indian J Med Sci. 2012;66(3\u20134):55\u201361.","journal-title":"Indian J Med Sci"},{"issue":"2","key":"1302_CR60","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00228-012-1321-7","volume":"69","author":"C Biagi","year":"2013","unstructured":"Biagi C, Montanaro N, Buccellato E, Roberto G, Vaccheri A, Motola D. Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region). Eur J Clin Pharmacol. 2013;69(2):237\u201344.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"1302_CR61","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4321\/S1886-36552012000400006","volume":"10","author":"A Prakasam","year":"2012","unstructured":"Prakasam A, Nidamanuri A, Kumar S. Knowledge, perception and practice of pharmacovigilance among community pharmacists in South India. Pharm Pract (Internet). 2012;10(4):222\u20136.","journal-title":"Pharm Pract (Internet)"},{"issue":"Suppl 1","key":"1302_CR62","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.4103\/0976-500X.120963","volume":"4","author":"C Giofr\u00e8","year":"2013","unstructured":"Giofr\u00e8 C, Scicchitano F, Palleria C, Mazzitello C, Ciriaco M, Gallelli L, et al. Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis. J Pharmacol Pharmacother. 2013;4(Suppl 1):S55-60.","journal-title":"J Pharmacol Pharmacother"},{"issue":"4","key":"1302_CR63","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3233\/JRS-2011-0543","volume":"23","author":"D Chopra","year":"2011","unstructured":"Chopra D, Wardhan N, Rehan HS. Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital. Int J Risk Saf Med. 2011;23(4):227\u201332.","journal-title":"Int J Risk Saf Med"},{"issue":"4","key":"1302_CR64","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4321\/S1886-36552011000400008","volume":"9","author":"S Palaian","year":"2011","unstructured":"Palaian S, Ibrahim MI, Mishra P. Health professionals\u2019 knowledge, attitude and practices towards pharmacovigilance in Nepal. Pharm Pract (Granada). 2011;9(4):228\u201335.","journal-title":"Pharm Pract (Granada)"},{"issue":"1","key":"1302_CR65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/pds.2021","volume":"20","author":"IA Oreagba","year":"2011","unstructured":"Oreagba IA, Ogunleye OJ, Olayemi SO. The knowledge, perceptions and practice of pharmacovigilance amongst community pharmacists in Lagos state, South West Nigeria. Pharmacoepidemiol Drug Saf. 2011;20(1):30\u20135.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1302_CR66","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1108\/09526861011010677","volume":"23","author":"A Moumtzoglou","year":"2010","unstructured":"Moumtzoglou A. Factors that prevent physicians reporting adverse events. Int J Health Care Qual Assur. 2010;23(1):51\u20138.","journal-title":"Int J Health Care Qual Assur"},{"issue":"5","key":"1302_CR67","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s11096-010-9420-y","volume":"32","author":"P Gavaza","year":"2010","unstructured":"Gavaza P, Brown CM, Khoza S. Texas pharmacists\u2019 opinions on reporting serious adverse drug events to the Food and Drug Administration: a qualitative study. Pharm World Sci. 2010;32(5):651\u20137.","journal-title":"Pharm World Sci"},{"issue":"3","key":"1302_CR68","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/pds.1792","volume":"19","author":"C Su","year":"2010","unstructured":"Su C, Ji H, Su Y. Hospital pharmacists\u2019 knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiol Drug Saf. 2010;19(3):217\u201322.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"1302_CR69","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/pds.1724","volume":"19","author":"JO Ohaju-Obodo","year":"2010","unstructured":"Ohaju-Obodo JO, Iribhogbe OI. Extent of pharmacovigilance among resident doctors in Edo and Lagos states of Nigeria. Pharmacoepidemiol Drug Saf. 2010;19(2):191\u20135.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1302_CR70","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1472-6904-9-14","volume":"9","author":"KA Oshikoya","year":"2009","unstructured":"Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9:14.","journal-title":"BMC Clin Pharmacol."},{"issue":"6","key":"1302_CR71","first-page":"324","volume":"35","author":"AA Elnour","year":"2009","unstructured":"Elnour AA, Ahmed AD, Yousif MA, Shehab A. Awareness and reporting of adverse drug reactions among health care professionals in Sudan. Jt Comm J Qual Patient Saf. 2009;35(6):324\u20139.","journal-title":"Jt Comm J Qual Patient Saf"},{"issue":"2","key":"1302_CR72","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11096-008-9276-6","volume":"31","author":"G Vessal","year":"2009","unstructured":"Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm World Sci. 2009;31(2):183\u20137.","journal-title":"Pharm World Sci"},{"issue":"1","key":"1302_CR73","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00228-008-0564-9","volume":"65","author":"E Ekman","year":"2009","unstructured":"Ekman E, B\u00e4ckstr\u00f6m M. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. Eur J Clin Pharmacol. 2009;65(1):43\u20136.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"1302_CR74","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/pds.1597","volume":"17","author":"EO Okezie","year":"2008","unstructured":"Okezie EO, Olufunmilayo F. Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug Saf. 2008;17(5):517\u201322.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"5","key":"1302_CR75","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s11096-008-9209-4","volume":"30","author":"HZ Toklu","year":"2008","unstructured":"Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556\u201362.","journal-title":"Pharm World Sci"},{"issue":"4","key":"1302_CR76","first-page":"187","volume":"6","author":"M Gossell-Williams","year":"2008","unstructured":"Gossell-Williams M, Adebayo SA. The Pharmwatch Programme: challenges to engaging the community pharmacists in Jamaica. Pharm Pract. 2008;6(4):187\u201390.","journal-title":"Pharm Pract"},{"issue":"11","key":"1302_CR77","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2165\/00002018-200730110-00006","volume":"30","author":"M Irujo","year":"2007","unstructured":"Irujo M, Beitia G, Bes-Rastrollo M, Figueiras A, Hern\u00e1ndez-D\u00edaz S, Lasheras B. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf. 2007;30(11):1073\u201382.","journal-title":"Drug Saf"},{"issue":"4","key":"1302_CR78","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1365-2753.2003.00456.x","volume":"10","author":"MT Herdeiro","year":"2004","unstructured":"Herdeiro MT, Polonia J, Gestal-Otero JJ, Figueiras A. Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional. J Eval Clin Pract. 2004;10(4):483\u20139. https:\/\/doi.org\/10.1111\/j.1365-2753.2003.00456.x.","journal-title":"J Eval Clin Pract"},{"issue":"4","key":"1302_CR79","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1590\/S0080-623420140000400023","volume":"48","author":"FR Varallo","year":"2014","unstructured":"Varallo FR, Guimar\u00e3es SOP, Abjaude SAR, Mastroianni PC. Causes for the underreporting of adverse drug events by health professionals: A systematic review. Rev da Esc Enferm. 2014;48(4):739\u201347. https:\/\/doi.org\/10.1590\/S0080-623420140000400023.","journal-title":"Rev da Esc Enferm."},{"key":"1302_CR80","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8569314","author":"AD Hailu","year":"2020","unstructured":"Hailu AD, Mohammed SA. Adverse drug reaction reporting in Ethiopia: systematic review. Biomed Res Int. 2020. https:\/\/doi.org\/10.1155\/2020\/8569314.","journal-title":"Biomed Res Int"},{"issue":"4","key":"1302_CR81","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/bcp.14179","volume":"86","author":"CR Herrera","year":"2020","unstructured":"Herrera CR. Undergraduate and postgraduate pharmacovigilance education: a proposal for appropriate curriculum content. Br J Clin Pharmacol. 2020;86(4):779\u201390. https:\/\/doi.org\/10.1111\/bcp.14179.","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 1","key":"1302_CR82","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.4103\/0253-7613.193314","volume":"48","author":"RK Tripathi","year":"2016","unstructured":"Tripathi RK, Jalgaonkar SV, Sarkate PV, Rege NN. Implementation of a module to promote competency in adverse drug reaction reporting in undergraduate medical students. Indian J Pharmacol. 2016;48(Suppl 1):S69\u201373. https:\/\/doi.org\/10.4103\/0253-7613.193314.","journal-title":"Indian J Pharmacol."},{"key":"1302_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0235591","volume":"15","author":"MP Shchory","year":"2020","unstructured":"Shchory MP, Goldstein LH, Arcavi L, Shihmanter R, Berkovitch M, Levy A. Increasing adverse drug reaction reporting-how can we do better? PLoS ONE. 2020;15:1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0235591.","journal-title":"PLoS ONE"},{"issue":"9","key":"1302_CR84","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1001\/jama.296.9.1086","volume":"296","author":"A Figueiras","year":"2006","unstructured":"Figueiras A, Herdeiro MT, Pol\u00f3nia J, Gestal-Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006;296(9):1086\u201393.","journal-title":"JAMA"},{"issue":"8","key":"1302_CR85","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2165\/11599750-000000000-00000","volume":"35","author":"MT Herdeiro","year":"2012","unstructured":"Herdeiro MT, Ribeiro-Vaz I, Ferreira M, Polnia J, Falco A, Figueiras A. Workshop-and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal. Drug Saf. 2012;35(8):655\u201365. https:\/\/doi.org\/10.2165\/11599750-000000000-00000.","journal-title":"Drug Saf"},{"issue":"1","key":"1302_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12909-020-02084-7","volume":"20","author":"S Shrestha","year":"2020","unstructured":"Shrestha S, Sharma S, Bhasima R, Kunwor P, Adhikari B, Sapkota B. Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital. BMC Med Educ. 2020;20(1):1\u201310. https:\/\/doi.org\/10.1186\/s12909-020-02084-7.","journal-title":"BMC Med Educ"},{"key":"1302_CR87","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/AMEP.S225208","volume":"11","author":"S Shrestha","year":"2020","unstructured":"Shrestha S, Shrestha R, Abidi A, et al. Workshop on adverse drug reaction reporting, pharmacovigilance and its implementation in cancer hospital in Nepal: an event report. Adv Med Educ Pract. 2020;11:9\u201314. https:\/\/doi.org\/10.2147\/AMEP.S225208.","journal-title":"Adv Med Educ Pract"},{"issue":"2","key":"1302_CR88","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/fampra\/20.2.199","volume":"20","author":"D Richards","year":"2003","unstructured":"Richards D, Toop L, Graham P. Do clinical practice education groups result in sustained change in GP prescribing? Fam Pr. 2003;20(2):199\u2013206. https:\/\/doi.org\/10.1093\/fampra\/20.2.199.","journal-title":"Fam Pr"},{"issue":"1","key":"1302_CR89","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13012-020-01011-0","volume":"15","author":"SL Yoong","year":"2020","unstructured":"Yoong SL, Hall A, Stacey F, Grady A, Sutherland R, Wyse R, et al. Nudge strategies to improve healthcare providers\u2019 implementation of evidence-based guidelines, policies and practices: a systematic review of trials included within Cochrane systematic reviews. Implement Sci. 2020;15(1):50. https:\/\/doi.org\/10.1186\/s13012-020-01011-0.","journal-title":"Implement Sci"},{"issue":"6","key":"1302_CR90","first-page":"1327","volume":"47","author":"J Feely","year":"1990","unstructured":"Feely J, Moriarty S, O\u2019Connor P. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions. Am J Hosp Pharm. 1990;47(6):1327\u201333.","journal-title":"Am J Hosp Pharm"},{"issue":"6716","key":"1302_CR91","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/bmj.300.6716.22","volume":"300","author":"J Feely","year":"1990","unstructured":"Feely J, Moriarty S, O\u2019Connor P. Stimulating reporting of adverse drug reactions by using a fee. BMJ (Clinical Res ed). 1990;300(6716):22\u20133. https:\/\/doi.org\/10.1136\/bmj.300.6716.22.","journal-title":"BMJ (Clinical Res ed)."},{"issue":"5","key":"1302_CR92","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00228-005-0072-0","volume":"62","author":"M B\u00e4ckstr\u00f6m","year":"2006","unstructured":"B\u00e4ckstr\u00f6m M, Mj\u00f6rndal T. A small economic inducement to stimulate increased reporting of adverse drug reactions\u2014a way of dealing with an old problem? Eur J Clin Pharmacol. 2006;62(5):381\u20135. https:\/\/doi.org\/10.1007\/s00228-005-0072-0.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"1302_CR93","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2165\/11597190-000000000-00000","volume":"35","author":"I Ribeiro-Vaz","year":"2012","unstructured":"Ribeiro-Vaz I, Santos C, Da Costa-Pereira A, Cruz-Correia R. Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal. Drug Saf. 2012;35(5):387\u201394. https:\/\/doi.org\/10.2165\/11597190-000000000-00000.","journal-title":"Drug Saf"},{"issue":"1","key":"1302_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12911-016-0265-8","volume":"16","author":"I Ribeiro-Vaz","year":"2016","unstructured":"Ribeiro-Vaz I, Silva AM, Costa Santos C, Cruz-Correia R. How to promote adverse drug reaction reports using information systems\u2014a systematic review and meta-analysis. BMC Med Inform Decis Mak. 2016;16(1):1\u201310. https:\/\/doi.org\/10.1186\/s12911-016-0265-8.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"12","key":"1302_CR95","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/pds.2027","volume":"19","author":"A Maguire","year":"2010","unstructured":"Maguire A, Douglas I, Smeeth L, Thompson M. Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting. Pharmacoepidemiol Drug Saf. 2010;19(12):1211\u20135. https:\/\/doi.org\/10.1002\/pds.2027.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1302_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pds.4906","volume":"29","author":"R Li","year":"2020","unstructured":"Li R, Zaidi STR, Chen T, Castelino R. Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: a systematic review. Pharmacoepidemiol Drug Saf. 2020;29(1):1\u20138. https:\/\/doi.org\/10.1002\/pds.4906.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"1302_CR97","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/ejhpharm-2012-000171","volume":"20","author":"AR Lander","year":"2013","unstructured":"Lander AR, Blicher TM, Jimenez-solem E, Jespersen M, Kampmann JP, Christensen HR. Introducing an adverse drug event manager. Eur J Hosp Pharm Sci Pract. 2013;20(2):78\u201381. https:\/\/doi.org\/10.1136\/ejhpharm-2012-000171.","journal-title":"Eur J Hosp Pharm Sci Pract."},{"issue":"5","key":"1302_CR98","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00228-008-0603-6","volume":"65","author":"M Johansson","year":"2009","unstructured":"Johansson M, Brunl\u00f6f G, Edward C, Wallerstedt SM. Effects of e-mails containing ADR information and a current case report on ADR reporting rate and quality of reports. Eur J Clin Pharmacol. 2009;65(5):511\u20134. https:\/\/doi.org\/10.1007\/s00228-008-0603-6.","journal-title":"Eur J Clin Pharmacol."},{"issue":"5","key":"1302_CR99","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2515\/therapie\/2014035","volume":"69","author":"D Abadie","year":"2014","unstructured":"Abadie D, Chebane L, Bert M, Durrieu G, Montastruc J. Online reporting of adverse drug reactions: a study from a French Regional Pharmacovigilance Center. Therapie. 2014;69(5):395\u2013400. https:\/\/doi.org\/10.2515\/therapie\/2014035.","journal-title":"Therapie"},{"issue":"3","key":"1302_CR100","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2165\/11594910-000000000-00000","volume":"35","author":"I Oosterhuis","year":"2012","unstructured":"Oosterhuis I, Van Hunsel FPAM, Van Puijenbroek EP. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands. Drug Saf. 2012;35(3):221\u201332. https:\/\/doi.org\/10.2165\/11594910-000000000-00000.","journal-title":"Drug Saf"},{"issue":"8","key":"1302_CR101","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1080\/14740338.2019.1632287","volume":"18","author":"AY Aldryhim","year":"2019","unstructured":"Aldryhim AY, Alomair A, Alqhtani M, et al. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia. Expert Opin Drug Saf. 2019;18(8):745\u201352. https:\/\/doi.org\/10.1080\/14740338.2019.1632287.","journal-title":"Expert Opin Drug Saf"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-023-01302-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-023-01302-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-023-01302-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T15:16:30Z","timestamp":1687187790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-023-01302-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":101,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1302"],"URL":"https:\/\/doi.org\/10.1007\/s40264-023-01302-7","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"26 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been funded in part by the Instituto de Salud Carlos III (ISCIII) through the project PI19\/01006, co-financed by FEDER, European Union.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Patricia Garc\u00eda-Abeijon, Catarina Costa, Margarita Taracido, Maria Teresa Herdeiro, Carla Torre, and Adolfo Figueiras have no conflicts of interest that are directly relevant to the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Conceptualization: AF, CT, MTH, MT. Article screening: PGA, CC. Writing\u2014original draft: PGA, CC. Writing\u2014review and editing: MT, MTH, CT, AF. Final approval: PGA, CC, MT, MTH, CT, AF. All authors read and approved the final version of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}